Results 1 to 10 of about 5,004,732 (313)

Choroidal thickness in healthy subjects

open access: yesJournal of Ophthalmic & Vision Research, 2018
Purpose: To measure the choroidal thickness by enhanced depth imaging optical coherence tomography (EDI-OCT) in normal eyes. Methods: In a prospective case series, 208 eyes of 104 normal Iranian subjects were enrolled. Complete ophthalmic examination was
Morteza Entezari   +5 more
doaj   +3 more sources

Mechanisms of dyspnea in healthy subjects [PDF]

open access: yesMultidisciplinary Respiratory Medicine, 2010
Dyspnea is a general term used to characterize a range of different descriptors; it varies in intensity, and is influenced by a wide variety of factors such as cultural expectations and the patient's experiences.
Gigliotti Francesco
doaj   +3 more sources

Effect of dietary supplementation with a new nutraceutical formulation on cardiometabolic risk factors: a double-blind, placebo-controlled, randomized clinical study

open access: yesArchives of Medical Science: Atherosclerotic Diseases, 2023
Introduction The scientific community and consumers are increasingly interested in the potential cholesterol-lowering effect of various nutraceuticals and their combinations.
Federica Fogacci   +4 more
doaj   +1 more source

Optimization of sniff nasal inspiratory pressure (SNIP) measurement methodology in healthy subjects

open access: yesBMC Pulmonary Medicine, 2023
Background Maximal inspiratory pressure (MIP) is currently the most commonly used measure for respiratory muscle strength (RMS) estimation, however, requires significant effort.
R. J. Wilding   +2 more
doaj   +1 more source

Population Pharmacokinetic Analysis of Cefaclor in Healthy Korean Subjects

open access: yesPharmaceutics, 2021
The aims of this study were: (1) to perform population pharmacokinetic analysis of cefaclor in healthy Korean subjects, and (2) to investigate possible effects of various covariates on pharmacokinetic parameters of cefaclor.
Seung-Hyun Jeong   +3 more
doaj   +1 more source

N-Terminal Pro-Brain Natriuretic Peptide (Nt-proBNP) Serum Concentrations in Apparently Healthy Bosnian Women

open access: yesBiomolecules & Biomedicine, 2007
Brain natriuretic peptide (BNP) is a cardiac hormone secreted predominantly from the ventricles. This hormone is produced as pre-prohormone BNP (pro BNP), than cleaved by corine to biologically active 32-aminoacid BNP and non-biologically active N ...
Almira Hadžović-Džuvo   +4 more
doaj   +1 more source

Exhaled Breath Condensate: Pilot Study of the Method and Initial Experience in Healthy Subjects

open access: yesActa Medica, 2018
Analysis of Exhaled breath condensate (EBC) is a re-discovered approach to monitoring the course of the disease and reduce invasive methods of patient investigation.
Eva Peterová   +7 more
doaj   +1 more source

A phase I study to evaluate the safety, tolerability, and pharmacokinetics of a novel, potent GABA analog HSK16149 in healthy Chinese subjects

open access: yesFrontiers in Pharmacology, 2023
Purpose: HSK16149 is a novel, potent gamma-aminobutyric acid (GABA) analog for the treatment of neuropathic pain. This study aimed to evaluate the safety, tolerability, and pharmacokinetics of HSK16149 after single and multiple doses in healthy Chinese ...
Qian Chen   +28 more
doaj   +1 more source

Gender Differences in the Prevalence of Electrocardiogram Abnormalities in the Elderly: A Population Survey in India [PDF]

open access: yesIranian Journal of Medical Sciences, 2012
Background: The health transition in India reflects the growing burden of cardiovascular diseases. It is well-known that there are significant and meaningful differences in the measured electrocardiogram (ECG) parameters between females and males ...
Rupali Sachin Khane, Anil D. Surdi
doaj  

A phase I, randomized, double-blind, parallel, single-dose pharmacokinetic study to evaluate the biosimilarity of KM118 (proposed pertuzumab biosimilar) with reference pertuzumab (Perjeta®) in healthy male subjects

open access: yesAnnals of Medicine
Objective KM118 is a biosimilar to pertuzumab (Perjeta®). This study aimed to prove the pharmacokinetics (PK) biosimilarity and evaluate the safety, tolerability, and immunogenicity of KM118 and the original drug Perjeta® so that it can be approved for ...
Yan Li   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy